stockrow
Friday 6 November 2026
Export FTRE’s income statement to Excel — free account
Fortrea Holdings Inc.
FTRE Healthcare Biotechnology
Fortrea Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 1.00% from fiscal 2024.
- Revenue
- −1.40%
- EPS
- +103.7%
- Free cash flow
- −34.0%
- Total debt
- −6.33%
Quarter to September 2026, against a year earlier
21.95
1.49
+7.28%
Follow FTRE
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 4 | 4 | 3 |
+8 more TTM periods Free account |
| (12.34%) | (15.30%) | (64.55%) | (102.41%) | ||
| (2.51%) | (3.07%) | (15.40%) | (31.33%) | ||
ROIC |
0.59% | (0.48%) | (15.53%) | (37.83%) | |
Return on Tangible Assets |
(53.67%) | (73.39%) | (408.13%) | (739.28%) | |
Average Days of Receivables |
87.75 | 89.24 | 83.49 | 79.03 | |
Free Cash Flow per Share |
1.79 | 2.09 | 2.03 | 0.97 | |
Free Cash Flow |
171.00 | 198.00 | 190.40 | 88.30 | |
Capital Expenditures |
(30.80) | (29.80) | (30.30) | (25.20) | |
| Other line items | |||||
Cash ROIC |
9.46% | 11.33% | 11.03% | 4.93% | |
Accounts Receivable Turnover |
4.09 | 3.84 | 4.02 | 4.36 | |
Accounts Payable Turnover |
41.63 | 29.43 | 24.28 | 26.44 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
9.07 | 9.16 | 11.76 | 4.88 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.30 | 0.10 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
15.35% | 15.41% | 16.06% | 16.76% | |
Share Based Compensation of Revenue |
1.90% | 2.28% | 2.63% | 2.73% | |
Interest Coverage |
0.16 | (0.13) | (4.04) | (9.55) | |
Operating CF/Net income |
(2.94) | (2.67) | (0.49) | (0.12) | |
Depreciation/Fixed assets |
0.50 | 0.50 | 2.47 | 5.86 | |
Capex/Depreciation |
(0.39) | (0.38) | (0.08) | (0.03) | |
Revenue per Share |
27.89 | 28.23 | 28.94 | 29.86 | |
Operating CF per Share |
2.11 | 2.40 | 2.36 | 1.24 | |
Capex per Share |
(0.32) | (0.31) | (0.32) | (0.28) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates · fundamentals updated 2 Nov 2026